NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Scripps-eMed Covid-19 Study: A Prospective Monitoring Study for Those Individuals Treated With Paxlovid

NCT05618600

CompletedN/A

Sponsor: Scripps Translational Science Institute

Conditions: COVID-19

Countries: United States

A prospective monitoring study for those individuals treated with Paxlovid

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Age \> 18
* Covid positive
* Qualified for Paxlovid prescription (treatment decision already made prior to enrollment)

Exclusion Criteria:

* Non-english speaking
* Resides outside of the United States

Locations (1)

San Diego, California, United States